Clinical Trial Update: A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates Janssen's study of Icotrokinra for moderately to severely active Crohn's disease is in Phase 2/Phase 3 and currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Icotrokinra (JNJ-77242113)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Crohn Disease | Phase 2, Phase 3 | Status: RECRUITING